Identifying compounds that indirectly alter the activity of C/EBPδ are not only valuable tools for those investigating C/EBPδ but also enhance our understanding of the mechanisms regulating C/EBPδ and are of potential relevance in diseases beyond cancer, where C/EBPδ is a known driver of disease progression. Here, CEBPD is linked to cancer.